๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Wuhan 139 Beijing 4 Chongqing 4 Changchun 3 Guangzhou 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165 Tongji Hospital139 Huazhong University of Science and Technology45 Novartis Pharmaceuticals33 AbbVie31 Clear sponsor filter
Site location
Wuhan139 Beijing4 Chongqing4 Changchun3 Guangzhou3
All 33 locations
Target enrolment
to
139 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
NCT06497387Lupus Nephritis, IgG4-related Disease
Tongji Hospital
Phase EARLY_PHASE1
30
Wuhan
2024-07
Recruiting
A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
NCT05303285Ankylosing Spondylitis (AS)
Tongji Hospital
Phase 4
100
Wuhan
2024-06-14
Recruiting
Spinal Versus General Anesthesia on Postoperative Pulmonary Complications
NCT06425627Pulmonary Complication, Anesthesia, Hip Fractures
Tongji Hospital
Not applicable
40
Wuhan
2024-06-12
Recruiting
Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
NCT06192797Cholangiocarcinoma Non-resectable
Tongji Hospital
Phase 2
36
Wuhan
2024-06-04
Recruiting
Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased ฮผ-Opioid Study
NCT06409689Postoperative Analgesia
Tongji Hospital
Not applicable
80
Wuhan
2024-06-01
Not yet open
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
NCT06089369Hepatocellular Carcinoma
Tongji Hospital
Phase 3
360
Wuhan
2024-06-01
Recruiting
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
NCT06289062Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Fertility Preservation
Tongji Hospital
Phase 2
40
Guangzhou, Wuhan
2024-05-08
Recruiting
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
NCT06288373Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy
Tongji Hospital
Phase 2/3
440
Hefei, Beijing, Chongqing, Lanzhou, Nanning, Wuhan, Changsha, Shenyang
2024-04-22
Recruiting
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
NCT06552598Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer
Tongji Hospital
Phase 1
97
Wuhan
2024-04-01
Active, closed
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
NCT06483425Ovarian Cancer, Biomarker
Tongji Hospital
Observational
2,000
Wuhan
2024-03-01
Recruiting
Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07699185Esophageal Squamous Cell Carcinoma
Tongji Hospital
Phase 2
336
Wuhan
2024-01-29
Recruiting
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
NCT06525909Hepatitis B, Chronic
Tongji Hospital
Observational
250
Wuhan, Beijing, Changchun, Chongqing, Nanjing
2024-01-20
Recruiting
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
NCT06149130Breast Cancer
Tongji Hospital
Phase 2
82
Wuhan
2024-01-11
By invitation
Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
NCT05788029Periampullary Adenocarcinoma
Tongji Hospital
Not applicable
212
Wuhan
2024-01-01
Recruiting
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
NCT06458972Systemic Lupus Erythematosus
Tongji Hospital
Observational
139
Wuhan
2024-01-01
Recruiting
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
NCT06236022Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection
Tongji Hospital
Phase 4
276
Wuhan
2024-01-01
Recruiting
Headache Registration and Followup Initiated by Tongji Hospital, HUST
NCT07269561Headache, Comorbidities
Tongji Hospital
Observational
50,000
Wuhan
2024-01-01
Recruiting
HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
NCT06187961Hepatocellular Carcinoma Non-resectable
Tongji Hospital
Phase 2
36
Wuhan
2023-12-30
Active, closed
Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
NCT06673134Crohn Disease
Tongji Hospital
Observational
100
Wuhan
2023-12-01
Not yet open
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
NCT06089382Hepatocellular Carcinoma
Tongji Hospital
Phase 3
104
Wuhan
2023-11-01
Recruiting
FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis
NCT06988852Colorectal Liver Metastasis (CRLM)
Tongji Hospital
Phase 2
300
Wuhan
2023-05-01
By invitation
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
NCT05635591EBV-associated Haematologic Neoplasms
Tongji Hospital
Phase 1
9
Wuhan
2023-01-16
Not yet open
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
NCT05510830Human Papilloma Virus Infection, Human Papilloma Virus Integration, Cervical Intraepithelial Neoplasia, Cervical Cancer
Tongji Hospital
Not applicable
250
Wuhan
2022-10
Active, closed
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
NCT05300932Systemic Sclerosis
Tongji Hospital
Phase 4
60
Wuhan
2022-03-08
Active, closed
Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
NCT07444905HCC - Hepatocellular Carcinoma, Machine Learning, Evaluation
Tongji Hospital
Observational
1,523
Wuhan
2022-02-01
Recruiting
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
NCT05206890Ovarian Cancer
Tongji Hospital
Observational
490
Wuhan
2022-01-14
Recruiting
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
NCT05141253Cancer
Tongji Hospital
Phase EARLY_PHASE1
24
Wuhan
2022-01-12
Recruiting
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
NCT05541367Breast Cancer, TNBC - Triple-Negative Breast Cancer, Estrogen-receptor-negative Breast Cancer
Tongji Hospital
Observational
80
Wuhan
2021-12-31
Recruiting
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202Inflammatory Cardiomyopathy, Myocarditis
Tongji Hospital
Phase 2/3
200
Wuhan
2021-11-01
Recruiting
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
NCT04847752Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis)
Tongji Hospital
Observational
1,000
Wuhan
2021-03-01
Active, closed
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
NCT04507841Ovarian Cancer
Tongji Hospital
Phase 2
67
Wuhan
2021-01-08
Recruiting
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
NCT04561557Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis
Tongji Hospital
Phase EARLY_PHASE1
36
Wuhan
2020-09-22
Recruiting
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
NCT05520788Hepatocellular Carcinoma, Biliary Tract Cancer
Tongji Hospital
Observational
200
Wuhan
2020-05-01
Recruiting
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
NCT05321758Crohn Disease
Tongji Hospital
Not applicable
50
Wuhan
2020-03-22
Recruiting
Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma
NCT03785743Pancreatic Carcinoma, Laparoscopic, Pancreaticoduodenectomy
Tongji Hospital
Not applicable
200
Wuhan
2019-03-01
Recruiting
Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
NCT07077473Familial Mediterranean Fever (FMF )
Tongji Hospital
Observational
12
Wuhan
2018-01-01
By invitation
Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome
NCT06688838Blau Syndrome
Tongji Hospital
Observational
24
Wuhan
2017-01-01
By invitation
Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease
NCT02751060Coronary Disease
Tongji Hospital
Observational
4,000
Wuhan
2016-04
Recruiting
AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
NCT07399236Colorectal Cancer Liver Metastases (CRLM)
Tongji Hospital
Observational
1,500
Wuhan
2015-01-01
Rows per page Showing 101–139 of 139
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.